Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio
Idiopathic pulmonary fibrosis (IPF) is the most common form of idiopathic interstitial pneumonia that is characterized by a steadily progressive course and poor prognosis. The worsening pulmonary fibrosis resulting in honeycomb lungs accounts for the deterioration of clinical symptoms and functional...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2018-10-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2682 |
_version_ | 1797842073174409216 |
---|---|
author | S. N. Avdeev N. V. Trushenko |
author_facet | S. N. Avdeev N. V. Trushenko |
author_sort | S. N. Avdeev |
collection | DOAJ |
description | Idiopathic pulmonary fibrosis (IPF) is the most common form of idiopathic interstitial pneumonia that is characterized by a steadily progressive course and poor prognosis. The worsening pulmonary fibrosis resulting in honeycomb lungs accounts for the deterioration of clinical symptoms and functional status in patients with IPF. Today, the drugs with anti-fibrotic properties are recommend as a drug therapy for IPF. The article provides information on the efficacy and safety of this therapy as well as practical guidelines on the management of patients with IPF receiving such therapy. |
first_indexed | 2024-04-09T16:41:49Z |
format | Article |
id | doaj.art-ec8b66b2ca6d4cc2a8954eb23ad1f523 |
institution | Directory Open Access Journal |
issn | 2079-701X 2658-5790 |
language | Russian |
last_indexed | 2024-04-09T16:41:49Z |
publishDate | 2018-10-01 |
publisher | Remedium Group LLC |
record_format | Article |
series | Медицинский совет |
spelling | doaj.art-ec8b66b2ca6d4cc2a8954eb23ad1f5232023-04-23T06:56:40ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-10-0101513113610.21518/2079-701X-2018-15-131-1362634Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratioS. N. Avdeev0N. V. Trushenko1Sechenov First Moscow State Medical University of the Ministry of Health of RussiaResearch Institute of Pulmonology of the Federal Medical-Biological Agency of RussiaIdiopathic pulmonary fibrosis (IPF) is the most common form of idiopathic interstitial pneumonia that is characterized by a steadily progressive course and poor prognosis. The worsening pulmonary fibrosis resulting in honeycomb lungs accounts for the deterioration of clinical symptoms and functional status in patients with IPF. Today, the drugs with anti-fibrotic properties are recommend as a drug therapy for IPF. The article provides information on the efficacy and safety of this therapy as well as practical guidelines on the management of patients with IPF receiving such therapy.https://www.med-sovet.pro/jour/article/view/2682idiopathic pulmonary fibrosistreatmentantifibrotic therapypirfenidone |
spellingShingle | S. N. Avdeev N. V. Trushenko Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio Медицинский совет idiopathic pulmonary fibrosis treatment antifibrotic therapy pirfenidone |
title | Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio |
title_full | Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio |
title_fullStr | Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio |
title_full_unstemmed | Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio |
title_short | Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio |
title_sort | antifibrotic therapy of idiopathic pulmonary fibrosis efficiency safety ratio |
topic | idiopathic pulmonary fibrosis treatment antifibrotic therapy pirfenidone |
url | https://www.med-sovet.pro/jour/article/view/2682 |
work_keys_str_mv | AT snavdeev antifibrotictherapyofidiopathicpulmonaryfibrosisefficiencysafetyratio AT nvtrushenko antifibrotictherapyofidiopathicpulmonaryfibrosisefficiencysafetyratio |